Publications by authors named "Kohei Motoshima"

Claim this Profile
P
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations.
Kosuke Mizoguchi, Yoichi Nakamura, Kazumi Sano, Shuntaro Sato, Yoji Ikegami, Kohei Motoshima

Cancer Chemother Pharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of amrubicin and nedaplatin in patients with untreated, advanced, non-small cell lung cancer.
Daiki Ogawara, Yoichi Nakamura, Minoru Fukuda, Katsumi Nakatomi, Hiroyuki Yamaguchi, Kohei Motoshima

Chemotherapy· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer.
Takaya Ikeda, Minoru Fukuda, Yoichi Nakamura, Akitoshi Kinoshita, Hiroaki Senju, Kohei Motoshima

Cancer Chemother Pharmacol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary EML4-ALK-positive lung adenocarcinoma in a patient previously treated for acute lymphoblastic leukemia in childhood: a case report.
Yoichi Nakamura, Hirokazu Taniguchi, Kosuke Mizoguchi, Takaya Ikeda, Kohei Motoshima

Jpn J Clin Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of erlotinib in patients with advanced non‑small‑cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics.
Kohei Motoshima, Yoichi Nakamura, Kazumi Sano, Yoji Ikegami, Takaya Ikeda

Cancer Chemother Pharmacol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of intratumor heterogeneity of EGFR mutations in mixed type lung adenocarcinoma.
Nanae Tomonaga, Yoichi Nakamura, Hiroyuki Yamaguchi, Takaya Ikeda, Kosuke Mizoguchi, Kohei Motoshima

Clin Lung Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe, but manageable hypoxia caused by bronchospasm induced by bevacizumab.
Hirokazu Taniguchi, Tomoko Tsuchida, Yoichi Nakamura, Kohei Motoshima, Kosuke Mizoguchi

Respirol Case Rep· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of lung cancer pain relief and safe return home by strontium chloride].
Kohei Motoshima, Minoru Fukuda, Yumi On, Kazunori Minami, Keiko Hisatomi

Gan To Kagaku Ryoho· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct comparison of 3 PCR methods in detecting EGFR mutations in patients with advanced non-small-cell lung cancer.
Takaya Ikeda, Yoichi Nakamura, Hiroyuki Yamaguchi, Nanae Tomonaga, Seiji Doi, Kohei Motoshima

Clin Lung Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of pulmonary cryptococcosis followed by pleuritis in an apparently immunocompetent patient during fluconazole treatment.
Koichi Izumikawa, Yong Zhao, Kohei Motoshima, Takahiro Takazono, Tomomi Saijo

Med Mycol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis